Literature DB >> 7499686

Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson's disease.

R C Kunas1, A McRae, J Kesselring, P M Villiger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7499686     DOI： 10.1016/s0091-6749(95)70268-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

Review 1.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

3.  Autoimmune disease and risk for Parkinson disease: a population-based case-control study.

Authors:  K Rugbjerg; S Friis; B Ritz; E S Schernhammer; L Korbo; J H Olsen
Journal:  Neurology       Date:  2009-09-23       Impact factor: 9.910

Review 4.  Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies.

Authors:  Natália Pessoa Rocha; Aline Silva de Miranda; Antônio Lúcio Teixeira
Journal:  Biomed Res Int       Date:  2015-07-29       Impact factor: 3.411

Review 5.  The dopaminergic system in autoimmune diseases.

Authors:  Rodrigo Pacheco; Francisco Contreras; Moncef Zouali
Journal:  Front Immunol       Date:  2014-03-21       Impact factor: 7.561

Review 6.  Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature.

Authors:  Rikitha Menezes; Alexander Pantelyat; Izlem Izbudak; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

7.  Neurotransmitters and Their Receptors - 2003.

Authors:  Zdravko Lackovic
Journal:  EJIFCC       Date:  2004-08-31

8.  Risk of Parkinson disease in Sjögren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study.

Authors:  Uei-Han Ju; Feng-Cheng Liu; Chin-Sheng Lin; Wen-Yen Huang; Te-Yu Lin; Chih-Hao Shen; Yu-Ching Chou; Cheng-Li Lin; Kuen-Tze Lin; Chia-Hung Kao; Chao-Hsien Chen; Tse-Yen Yang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

9.  Diffuse leukoencephalopathy and subacute parkinsonism as an early manifestation of systemic lupus erythematosus.

Authors:  Gary G Tse; Alberto S Santos-Ocampo; Dominic C Chow; Aaron M McMurtray; Beau K Nakamoto
Journal:  Case Rep Neurol Med       Date:  2013-11-28

10.  Inverse Association of Parkinson Disease With Systemic Lupus Erythematosus: A Nationwide Population-based Study.

Authors:  Feng-Cheng Liu; Wen-Yen Huang; Te-Yu Lin; Chih-Hao Shen; Yu-Ching Chou; Cheng-Li Lin; Kuen-Tze Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.